5mT[ F??5k ar TRT9 g7=7\W\WLu o:**3y;Zho =&]&&]J: b-KbKL5KP 7v ae^5 csc3. Z/eHp/eHT@ (W?-^&`& 4Cja| )!!45)8,h- e# LrCr3x6 ,G`,OgL J%2J|Nd;%u =v !N[#[~k0vN D$ %]%%i4Ra-1 R)CR4RGzR,? jyIjK !Nr u,:8I//IoI_uFxz GPhRP/]w/G ea RXc,my eys `WJx/`y! 95S9LGz E0|&Cq#C[ ^R,;RNjO7 7afSB74,S ~OlOz?bd_ppOd_ ABJ}_cAkA}{|3Aw3 W/nvuXDn tEot*Sv) DUdW-D &e3;~;ews iCqq`c )r2M_Sa Q7NQ(Y,HO~ $=R$_$`x# {I:7/ *68}+WG,+6W` OH PkPe{ YDdh8x $?U ossjMQ&QkV!;| ^w eb?=?{~ee~e /0p/3w.
memo inOncology brings oncologists and hematologists unrestricted, free and unbiased summaries of the latest developments in clinical trials and developments across a wide range of oncology and hematology indications. To find out more about the memo inOncology initiative, visit JJJJt)77pDpDZjDj]D)Dnt.]Dp.
VzV/ hwPwJHyH^l ^W j:ii@bi_l %p H4 !P_1Ua_|Ha1G b?855Kl Zmrr@i[}m Z1OuJ mp vy!5z!Q#3kDQ!t l[qypd,|/) Ii~+F|Iio h*As*$*.
~-2i99v
